Exiqon selected as winner in the BIOTECH 2005 category
Exiqon A/S, a leading supplier of high-value gene expression analysis products announces that it has won the Ernst & Young Entrepreneur Of The Year award in the category Biotech 2005. The prestigious award is created to identify and acknowledge the most successful and entrepreneurial Danish companies. A minimum growth of 15% in sales as well as growth in staff is among the key nomination criteria.
An impressive turnaround of the company in just 2 years, a successful business strategy and break-through research results were some of the points emphasized by the jury when Exiqon was named the best biotech company in Ernst & Young Entrepreneur of the Year competition. Exiqon’s ProbeLibrary™ product as well as its novel miRCURY™ microRNA detection product line were key elements of the successful growth of the company.
“We are very proud to receive this important award,” says Lars Kongsbak, President and CEO of Exiqon. “What we are seeing are the first results of Exiqon’s strategy to develop and market competitive products based on our LNA™ technology”, and adds, “We expect Exiqon’s revenue for 2005 to reach 5-6 million USD”.
The Ernst & Young award follows a successful past year where the Exiqon CEO won the award as Biotech Builder of the year, and Exiqon was named among the Top 100 most Innovative companies worldwide by the magazine RedHerring.